Owing to the propensity for visual loss, immunosuppressive treatment in the form of systemic and/or local therapy is often required for the management of noninfective intermediate and posterior ...

An estimated five to ten percent of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need ...

(HealthDay News) — Most patients with multiple sclerosis (MS) and uveitis present with intermediate uveitis, according to research presented at the annual meeting of the American Academy of ...

Vitreous cysts are rare structural entities that have been reported sporadically in the literature. Several associations have been described, including retinitis pigmentosa, Toxoplasmosis, trauma, ...

Please provide your email address to receive an email when new articles are posted on . Macular edema resolved faster after treatment with oral corticosteroids than with sub-Tenon's injections in ...

Expert Rev Ophthalmol. 2012;7(6):587-594. Multiple sclerosis (MS) is a neurodegenerative disease that causes demyelination of the CNS. MS can cause a wide variety of neuro-ophthalmic manifestations ...

Ophthalmologist_TS_78024029 An injectable fluocinolone acetonide long-acting implant may be able to effectively control intraocular inflammation, as well as improve visual acuity, in patients with a ...

Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis, an eye disease that ...

Q. I’m 64 and have been diagnosed with uveitis in my right eye. What causes it, and what’s the best treatment? A. Uveitis is inflammation of one or more of the parts of the uvea, the layer of tissue ...

Results from a recent study support prior findings of the association between MS and uveitis. A diagnosis of uveitis conferred a significantly higher risk of subsequent or coincident MS and a vast ...